Therapeutic use of proanthocyanidine A2 as a cytoprotective agent
US4925870A · kind A · utility
5Cited by
1References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 25, 1989 |
| Grant date | May 15, 1990 |
| Priority date | — |
| Expiry date | May 25, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for modifying conditions of impaired capillary permeability and resistance and for obtaining an anti-lipid peroxidation effect. There are also described pharmaceutical formulations suitable for use by topical and systemic routes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.